Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INTRA-CELLULAR THERAPIES, INC.

(ITCI)
  Report
Delayed Nasdaq  -  04:00 2022-12-02 pm EST
54.08 USD   +1.18%
11/10Intra-Cellular Therapies to Participate at Two Upcoming Investor Conferences
AQ
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperform Rating
MT
11/03Intra-Cellular Therapies Reports Narrower Q3 Loss, Higher Revenue; Shares Jump
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on INTRA-CELLULAR THERAPIES, INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) INTRA-CELLULAR THERAPIES, INC.
Analyst Recommendations on INTRA-CELLULAR THERAPIES, INC.
11/04RBC Lifts Price Target on Intra-Cellular Therapies to $69 From $67, Maintains Outperform R..
MT
10/06RBC Cuts Price Target on Intra-Cellular Therapies to $67 From $70, Maintains Outperform Ra..
MT
08/22Analyst recommendations: Snowflake, Vipshop, UIta Beauty, VF, Advance Auto Parts...
MS
08/22Goldman Sachs Cuts Intra-Cellular Therapies to Neutral From Buy, Price Target to $49 From ..
MT
08/11Mizuho Securities Adjusts Intra-Cellular Therapies' Price Target to $72 From $75, Keeps Bu..
MT
08/10Needham Adjusts Intra-Cellular Therapies' Price Target to $67 from $65, Keeps Buy Rating
MT
08/10Goldman Sachs Lowers Intra-Cellular Therapies' Price Target to $64 From $71, Maintains Buy..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 53,45 $
Average target price 68,58 $
Spread / Average Target 28,3%
High Price Target 93,00 $
Spread / Highest target 74,0%
Low Price Target 50,00 $
Spread / Lowest Target -6,45%
Consensus detail
Consensus revision (last 18 months)